Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Correlation between TP53, KRAS, SMAD4 and other mutations profile and neoadjuvant therapy efficacy and prognosis in locally advanced rectal cancer.
Authors
Tomohiro Takeda
Department of Surgery, Asahikawa Medical University, Asahikawa, Japan
Tomohiro Takeda , Yusuke Mizukami , Kai Makino , Hiroki Takahata , Ryotaro Shimazaki , Mizuho Ohara , Chikayoshi Tani , Kengo Kita , Kimiharu Hasegawa , Yusuke Ono , Mishie Tanino , Hideki Yokoo , Yasuo Sumi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 186)
DOI
10.1200/JCO.2024.42.3_suppl.186
Abstract #
186
Poster Bd #
L14
Abstract Disclosures
Similar Posters
Poster
2020 Gastrointestinal Cancers Symposium
Clinical utility of targeted next generation sequencing (NGS) to predict response to neoadjuvant therapy (NT) in rectal cancer (RC).
First Author: Kristen Carroll
Poster
2014 Gastrointestinal Cancers Symposium
Next-generation sequencing yields promising targets in advanced cholangiocarcinoma (CCA).
First Author: Rachna T. Shroff
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Genomic alteration in sporadic adolescent and young adult-onset colorectal adenocarcinoma.
First Author: Krittiya Korphaisarn
First Author: Sandra Algaze